Suppr超能文献

南亚人和欧洲人白细胞抗原基因座与风湿性心脏病易感性。

The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans.

机构信息

The Wellcome Centre for Human Genetics, University of Oxford, Oxford, Oxfordshire, OX3 7BN, UK.

Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, 226025, Uttar Pradesh, India.

出版信息

Sci Rep. 2020 Jun 2;10(1):9004. doi: 10.1038/s41598-020-65855-8.

Abstract

Rheumatic heart disease (RHD), an autoinflammatory heart disease, was recently declared a global health priority by the World Health Organization. Here we report a genome-wide association study (GWAS) of RHD susceptibility in 1,163 South Asians (672 cases; 491 controls) recruited in India and Fiji. We analysed directly obtained and imputed genotypes, and followed-up associated loci in 1,459 Europeans (150 cases; 1,309 controls) from the UK Biobank study. We identify a novel susceptibility signal in the class III region of the human leukocyte antigen (HLA) complex in the South Asian dataset that clearly replicates in the Europeans (rs201026476; combined odds ratio 1.81, 95% confidence intervals 1.51-2.18, P = 3.48×10). Importantly, this signal remains despite conditioning on the lead class I and class II variants (P = 0.00033). These findings suggest the class III region is a key determinant of RHD susceptibility offering important new insight into pathogenesis while partly explaining the inconsistency of earlier reports.

摘要

风湿性心脏病(Rheumatic Heart Disease,RHD)是一种自身炎症性心脏病,最近被世界卫生组织列为全球卫生重点关注疾病。在此,我们报告了一项针对 1163 名南亚人(672 例病例;491 名对照)的风湿性心脏病易感性全基因组关联研究(GWAS),这些人是在印度和斐济招募的。我们分析了直接获得和推断的基因型,并在来自英国生物库研究的 1459 名欧洲人(150 例病例;1309 名对照)中对相关基因座进行了随访。我们在南亚人群数据集的人类白细胞抗原(HLA)复合物的 III 类区域中发现了一个新的易感性信号,该信号在欧洲人群中得到了明确的复制(rs201026476;合并优势比 1.81,95%置信区间 1.51-2.18,P = 3.48×10)。重要的是,即使在考虑到主要的 I 类和 II 类变体的情况下,这种信号仍然存在(P = 0.00033)。这些发现表明 III 类区域是风湿性心脏病易感性的关键决定因素,为发病机制提供了重要的新见解,同时部分解释了早期报告的不一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验